In 1978 was created IDEO, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Palo Alto.
The current fund was established by David Kelley. Besides them, we counted 14 critical employees of this fund in our database.
The top activity for fund was in 2017. The top amount of exits for fund were in 2019. When the investment is from IDEO the average startup value is 5-10 millions dollars. Considering the real fund results, this Corporate Investor is 2 percentage points more often commits exit comparing to other organizations. This IDEO works on 1 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the IDEO, startups are often financed by SMBC Venture Capital, NEC Capital Solutions, Shinji Kimura. The meaningful sponsors for the fund in investment in the same round are D4V - Design for Ventures, SMBC Venture Capital, NEC Capital Solutions. In the next rounds fund is usually obtained by Crossbow Ventures, Eric Di Benedetto, D4V - Design for Ventures.
Among the most popular fund investment industries, there are Health Care, Education. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Arena Solutions, PillPack, Infarm
Related Funds
Fund Name | Location |
Asimov Ventures | New York, New York, United States |
Bienville Capital | New York, New York, United States |
Bridgewater Associates | Connecticut, United States, Westport |
Chicago Venture Summit | Chicago, Illinois, United States |
China Steel | Kaohsiung, Taiwan |
Columbus Nova | New York, New York, United States |
Genavent | - |
Hong Leong Bank | Indonesia, Kalimantan Barat, Kuala |
Jinxin Gongxiao Fund | Beijing, Beijing, China |
Karsh Family Foundation | - |
MBK Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
Previz Ventures | Herzliya, Israel, Tel Aviv |
Redwood Technologies | - |
Shanxi Shenggao Jishu Fuwu Chuangtou | China, Shaanxi, Xian Shi |
Solel Investment Group | New York, New York, United States |
Structural Capital | California, Menlo Park, United States |
SunShot Initiative fund | - |
Tower Capital Partners | New York, Suffern, United States |
Yellowdog | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
EarlyBird | $4M | 01 Nov 2023 | Chicago, Illinois, United States | ||
LifeScore | $15M | 07 Mar 2022 | Salisbury, Wiltshire, United Kingdom | ||
Curve Health | $12M | 06 Feb 2022 | New York, New York, United States | ||
Sequin | $5M | 15 Sep 2021 | San Francisco, California, United States | ||
omniX labs | $750K | 01 Jan 2018 | New York, New York, United States | ||
Infarm | $4M | 26 Jun 2017 | Berlin | ||
Elemetric | 24 Apr 2017 | Chicago, Illinois, United States | |||
Alpaca | $1M | 24 Jan 2017 | California, United States | ||
Catalia Health | $1M | 12 Jun 2015 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
EarlyBird | $4M | 01 Nov 2023 | Chicago, Illinois, United States | ||
LifeScore | $15M | 07 Mar 2022 | Salisbury, Wiltshire, United Kingdom | ||
Curve Health | $12M | 06 Feb 2022 | New York, New York, United States | ||
Sequin | $5M | 15 Sep 2021 | San Francisco, California, United States | ||
omniX labs | $750K | 01 Jan 2018 | New York, New York, United States | ||
Infarm | $4M | 26 Jun 2017 | Berlin | ||
Elemetric | 24 Apr 2017 | Chicago, Illinois, United States | |||
Alpaca | $1M | 24 Jan 2017 | California, United States | ||
Catalia Health | $1M | 12 Jun 2015 | San Francisco, California, United States |